FDA shuffles top drug, biologics leaders in latest shakeup
The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, according to a memo seen by CNBC. The shake up caps a tumultuous week at the FDA.
Institutional-grade analytics, real-time data, and AI research tools — built for investors who think in decades, not days.
Explore the Platform →
A stronger dollar is back on center stage as Treasury yields jump and risk appetite fades. That matters less for FX tourists than for earnings translation, emerging-market liquidity, and the next leg of equity multiple compression.
Read more →
The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, according to a memo seen by CNBC. The shake up caps a tumultuous week at the FDA.
The sharp rally off of the March 30th low has seen the Nasdaq climb 25.9%. In percentage terms, the Nasdaq was down 8.4% below that same moving average, which was a lot, but far from any sort of record-setting reading.
The S&P 500 has been driven higher by large-cap hyperscalers and semiconductors over the last month. The index would need to fall 8% just to get back down to its 50-DMA from these levels.
All three major indexes stumbled on Friday as inflation worries and geopolitical concerns dampened market optimism.
South Korea is often-overlooked but its stock market is the hottest in the world this year. The boom is led by chip powerhouses SK Hynix and Samsung Electronics.
CNBC's Jim Cramer warned that rising bond yields could threaten the stock market rally and reduce the chances of interest rate cuts. He turned to the week ahead, highlighting reports from Nvidia, retailers and housing-related names.
American lender Forbright on Friday filed for an initial public offering in the United States.
Sam Vadas turns to China for Friday's final takeaways, offering her perspective on the key U.S. victories she sees in President Trump's overseas trip.
Short selling and put buying indicators continue to signal further upside for the technology sector rally. Current levels of bearish sentiment, measured by short fund activity and tech put buying, remain elevated and not yet contrarian-bearish.
The Federal Reserve said that outgoing Chair Jerome Powell would remain as its acting leader until Kevin Warsh, who was confirmed to a four-year term by the Senate this week, could be sworn in.
Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec. -------- More on Bloomberg Television and Markets Like this video?
The yield on the 10-year Treasury climbed to nearly 4.6% Friday, its highest level in more than a year.
What a year it's been so far. YTD, the S&P 500 is up 8.22%, and the Nasdaq is up 12.8%. And the year is not even half over yet. What a difference a couple of months can make.
The selloff gathered steam after the 30-year Treasury yield shot above 5.1%, approaching levels not seen in nearly two decades.
US stocks fell sharply on Friday as rising Treasury yields, surging oil prices, and fading enthusiasm surrounding artificial intelligence stocks pressured markets following weeks of record-setting gains. The Dow Jones Industrial Average dropped roughly 537 points, or about 1.1%, while the S&P 500 lost approximately 1.2%.
Investors are pouring money quickly into a new ETF that invests in companies involved with photonics and photolithography.
Jerome Powell's time leading the Federal Reserve is officially coming to an end. We look back at some of the defining moments of Powell's tenure, from the pandemic and emergency rate cuts to inflation, banking turmoil, and growing political scrutiny surrounding the Fed.
One result of the massive monetary expansion was an upsurge in inflation, to a peak of over 9% in 2022—which the Fed infamously termed “transitory.”
"Bloomberg Real Yield" highlights the market-moving news you need to know. Today's guests: Columbia Threadneedle Portfolio Manager, Total Return Bond Ed Al-Hussainy, JPMorgan Management CIO of US GFICC Kay Herr, CreditSights Global Head of Credit Strategy Winnie Cisar, and Ironsides Macroeconomics Director of Research Barry Knapp.
The stock market's momentum is not built on borrowed time.